ArticleInflammation2025
Role of Interleukin-6 Mediated T Cell Activation in Experimental Acute Pancreatitis.
Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- IL-4/STAT6-signaling Influences Local Inflammation and Regeneration Processes During Acute Pancreatitis and Promotes Fibrosis by a Direct Activation of Pancreatic Fibroblasts During Chronic Pancreatitis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute pancreatitis (AP) is an inflammatory disease characterized by a prominent local infiltration and activation of innate immune cells, but also accompanied by a systemic T cell activation. The mechanisms which link the local immune response to the systemic immune activation are not well understood. Here, we identified Interleukin-6 (IL-6) as a crucial mediator of systemic T cell activation, which is mainly released by pancreatic macrophages and necrotic acinar cells. IL-6 triggers the systemic T cell activation of CD4+ T helper cells. After the onset of acute pancreatitis IL-6 serum levels increase rapidly and affect the systemic immune reaction. A CD4+ specific knock out of the IL-6 receptor glycoprotein 130 receptor (GP130R), showed reduced proliferation and a higher apoptosis rate of T cells after induction of caerulein-induced AP. This diminished T cell activation results in a significant decrease of pancreatic macrophage proliferation and a milder disease course. Our data indicate a critical role of IL-6 in the crosstalk between local and systemic immune responses during AP, as well as a triggering role in adaptive immune mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.